BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2219 related articles for article (PubMed ID: 33709868)

  • 1. Pharmacokinetic drug interactions between antiseizure medications and drugs for comorbid diseases in children with epilepsy.
    Zaccara G; Lattanzi S; Russo E
    Expert Opin Drug Metab Toxicol; 2021 May; 17(5):595-610. PubMed ID: 33709868
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic considerations about antiseizure medications in the elderly.
    Roberti R; Palleria C; Nesci V; Tallarico M; Di Bonaventura C; Cerulli Irelli E; Morano A; De Sarro G; Russo E; Citraro R
    Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):983-995. PubMed ID: 32757857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug treatments in patients with cardiac diseases and epilepsy.
    Zaccara G; Lattanzi S; Cincotta M; Russo E
    Acta Neurol Scand; 2020 Jul; 142(1):37-49. PubMed ID: 32259277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of pharmacokinetic drug interactions between antimicrobial and antiseizure medications in children.
    Zaccara G; Lattanzi S
    Epileptic Disord; 2021 Apr; 23(2):229-256. PubMed ID: 33814360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond.
    Löscher W; Klein P
    CNS Drugs; 2021 Sep; 35(9):935-963. PubMed ID: 34145528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A profile of azetukalner for the treatment of epilepsy: from pharmacology to potential for therapy.
    Lattanzi S; Trinka E; Meletti S; Striano P; Matricardi S; Silvestrini M; Brigo F
    Expert Rev Clin Pharmacol; 2024; 17(5-6):423-432. PubMed ID: 38571335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What has been the impact of new drug treatments on epilepsy?
    Chen Z; Brodie MJ; Kwan P
    Curr Opin Neurol; 2020 Apr; 33(2):185-190. PubMed ID: 32049739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological aspects of antiseizure medications: From basic mechanisms to clinical considerations of drug interactions and use of therapeutic drug monitoring.
    Johannessen Landmark C; Eyal S; Burns ML; Franco V; Johannessen SI
    Epileptic Disord; 2023 Aug; 25(4):454-471. PubMed ID: 37259844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-drug interactions between antiseizure medications and antipsychotic medications: a narrative review and expert opinion.
    Besag FMC; Berry D; Vasey MJ; Patsalos PN
    Expert Opin Drug Metab Toxicol; 2023; 19(11):829-847. PubMed ID: 37925741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Fractures and Other Injuries in Children Treated with Antiseizure Medications for Epilepsy.
    Kumar SM; Simm PJ; De Silva L M; Gorelik A; Freeman JL; Mackay MT; Ahmad BS; Petty SJ; Wark JD
    Calcif Tissue Int; 2021 Aug; 109(2):139-146. PubMed ID: 33829290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal of antiseizure medications - for whom, when, and how?
    Brigo F; Broggi S; Lattanzi S
    Expert Rev Neurother; 2023 Apr; 23(4):311-319. PubMed ID: 36946546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between antiseizure medications and contraception: A study about the knowledge of patients and their specialist physicians.
    Gosset A; Denuelle M; Valton L; Sommet A; Bénévent J; Tremollières F
    Epilepsy Behav; 2022 Apr; 129():108627. PubMed ID: 35240507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Basis of Medication Therapy for Epilepsy].
    Hanaya R
    No Shinkei Geka; 2023 Jan; 51(1):95-104. PubMed ID: 36682754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectionality of antiseizure and antipsychotic treatment: A population-based study.
    Revdal E; Morken G; Bakken IJ; Bråthen G; Landmark CJ; Brodtkorb E
    Epilepsy Behav; 2022 Nov; 136():108911. PubMed ID: 36126553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability of Antiseizure Medications in Individuals With Newly Diagnosed Epilepsy.
    Alsfouk BAA; Brodie MJ; Walters M; Kwan P; Chen Z
    JAMA Neurol; 2020 May; 77(5):574-581. PubMed ID: 32091535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the use of antiseizure medications in children and adolescents in Norway, 2009-2018.
    Heger K; Skipsfjord J; Kiselev Y; Burns ML; Aaberg KM; Johannessen SI; Skurtveit S; Johannessen Landmark C
    Epilepsy Res; 2022 Mar; 181():106872. PubMed ID: 35180640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal administration of antiseizure medications in chronic and emergency treatment: Hopes and challenges.
    Chmielewska N; Szyndler J
    Seizure; 2024 Feb; 115():62-67. PubMed ID: 38184900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between antiseizure medications and quality of life in epilepsy: A mediation analysis.
    Wang M; Perera K; Josephson CB; Lamidi M; Lawal OA; Awosoga O; Roach P; Patten SB; Wiebe S; Sajobi TT
    Epilepsia; 2022 Feb; 63(2):440-450. PubMed ID: 34931300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A narrative review of the importance of pharmacokinetics and drug-drug interactions of preventive therapies in migraine management.
    Joshi S; Tepper SJ; Lucas S; Rasmussen S; Nelson R
    Headache; 2021 Jun; 61(6):838-853. PubMed ID: 34214182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Not your usual drug-drug interactions: Monoclonal antibody-based therapeutics may interact with antiseizure medications.
    Berman E; Noyman I; Medvedovsky M; Ekstein D; Eyal S
    Epilepsia; 2022 Feb; 63(2):271-289. PubMed ID: 34967010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 111.